NHP Models > Co-develop

Clinical trials are a critical component of the drug development process, involving millions of participants worldwide. However, despite their importance, the high failure rate and presence of controls in these trials mean that many participants do not experience significant benefits. To address this issue and advance drug research and development, Prisys is dedicated to improving the scientific understanding of new drug successes in human trials, thereby accelerating progress towards improving human health.

At Prisys, we are committed to advancing nonhuman primate pharmacology, with the ultimate goal of transitioning from Non-Human Primate Clinic to Human Patient Clinic (NHPC to HPC). We invite collaborations from researchers worldwide to advance innovative NHP pharmacology. Our state-of-the-art NHP clinical center offers a wide range of services, including standard commercial CRO services, flexible collaboration arrangements for accessing NHP resources, modeling technologies, disease specialties, translational research, and clinical capabilities. These capabilities enable the efficient translation of NHP studies into their clinical applications, ultimately accelerating the development of safe and effective drugs for human patients.

Prisys provides a variety of cooperative development options that enable customers to collaborate with Prisys in research and development. These options include joint development, exclusive or shared property rights, and long-term research agreements. The focus of this model is on the development of special frontier models, specifically in the fields of cancer and gynecology.

In the joint development option, Prisys and the customer collaborate to develop a new product. The customer retains ownership of any intellectual property they contribute, and the resulting product may be jointly owned or may have exclusive or shared property rights.

Through long-term research agreements, Prisys and the customer can work together on research projects over an extended period of time. This approach allows Prisys to offer specialized support to customers in developing new products or technologies.

The cooperative development model is particularly beneficial for special frontier models like cancer and gynecology, where the development of new treatments and therapies requires extensive scientific expertise and resources. Prisys and its customers can leverage their respective strengths to achieve successful outcomes in these challenging fields.

Endometrium lesion biopsies performed under laparoscopy